Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -130.67% is 46% below its 5-year average of -89.80%, around the middle of its 5-year range (-195.43%–-32.54%).
As of the fiscal period ended Friday, July 31, 2026. 3.77% above its 12-month average of -135.79%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-07-31): -130.67%.
RETURN ON EQUITY (ROE)
-130.67%
RETURN ON EQUITY (ROE) AVG TTM
-135.79%
RETURN ON EQUITY (ROE) AVG 3Y
-111.44%
RETURN ON EQUITY (ROE) AVG 5Y
-89.80%
RETURN ON EQUITY (ROE) AVG 10Y
-99.57%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+3.77%
CURRENT VS 3Y AVG
-17.26%
CURRENT VS 5Y AVG
-45.51%
CURRENT VS 10Y AVG
-31.23%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.30%
median of 608 covered companies
CURRENT VS SECTOR MEDIAN
-224.20%
vs the sector median at left
Nutriband Inc.
Market Cap
$80.47M
Return on Equity (ROE)
-130.67%
TTM Avg
-135.79%
3Y Avg
-111.44%
5Y Avg
-89.80%
Market Cap
$82.29M
Return on Equity (ROE)
232.78%
TTM Avg
-18.33%
3Y Avg
-28.65%
5Y Avg
-29.96%
Market Cap
$82.75M
Return on Equity (ROE)
-28.85%
TTM Avg
-24.95%
3Y Avg
-20.92%
5Y Avg
-19.20%
Market Cap
$82.26M
Return on Equity (ROE)
-114.06%
TTM Avg
-50.52%
3Y Avg
-45.18%
5Y Avg
-45.18%
Market Cap
$83.04M
Return on Equity (ROE)
-85.65%
TTM Avg
-57.41%
3Y Avg
-45.73%
5Y Avg
-8.61%
Market Cap
$79.98M
Return on Equity (ROE)
-122.76%
TTM Avg
-82.75%
3Y Avg
-63.80%
5Y Avg
-49.10%
Market Cap
$78.76M
Return on Equity (ROE)
-1542.57%
TTM Avg
-254.55%
3Y Avg
-187.52%
5Y Avg
-143.69%
Market Cap
$85.55M
Return on Equity (ROE)
-85.48%
TTM Avg
1586.35%
3Y Avg
184842.55%
5Y Avg
123293.37%
Market Cap
$85.17M
Return on Equity (ROE)
-150.95%
TTM Avg
-77.89%
3Y Avg
-62.90%
5Y Avg
-47.80%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nutriband Inc. (NTRB) | $80.47M | -130.67% | -135.79% | -111.44% | -89.80% |
| LENSAR Inc (LNSR)vs › | $82.29M | 232.78% | -18.33% | -28.65% | -29.96% |
| MediciNova, Inc. (MNOV)vs › | $82.75M | -28.85% | -24.95% | -20.92% | -19.20% |
| Citius Oncology, Inc. (CTOR)vs › | $82.26M | -114.06% | -50.52% | -45.18% | -45.18% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $83.04M | -85.65% | -57.41% | -45.73% | -8.61% |
| Pulmonx Corporation (LUNG)vs › | $79.98M | -122.76% | -82.75% | -63.80% | -49.10% |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.76M | -1542.57% | -254.55% | -187.52% | -143.69% |
| ProMIS Neurosciences, Inc. (PMN)vs › | $85.55M | -85.48% | 1586.35% | 184842.55% | 123293.37% |
| Cardiff Oncology, Inc. (CRDF)vs › | $85.17M | -150.95% | -77.89% | -62.90% | -47.80% |
| Cognition Therapeutics, Inc. (CGTX)vs › | $85.01M | -50.80% | -124.86% | -88.30% | -60.21% |
ROE
-130.7%
ROA
-110.6%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-07-31 | -130.67% |
| 2026-04-30 | -134.94% |
| 2026-01-31 | -123.21% |
| 2025-10-31 | -169.26% |
| 2025-07-31 | -120.89% |
| 2025-04-30 | -195.43% |
| 2025-01-31 | -163.04% |
| 2024-10-31 | -60.96% |
| 2024-07-31 | -58.13% |
| 2024-04-30 | -47.65% |
| 2024-01-31 | -85.20% |
| 2023-10-31 | -92.51% |
| 2023-07-31 | -66.80% |
| 2023-04-30 | -62.40% |
| 2023-01-31 | -52.44% |
| 2022-10-31 | -67.67% |
| 2022-07-31 | -68.04% |
| 2022-04-30 | -59.15% |
| 2022-01-31 | -52.08% |
| 2021-10-31 | -32.54% |
| 2021-07-31 | -42.79% |
| 2021-04-30 | -36.20% |
| 2021-01-31 | -41.24% |
| 2020-10-31 | -22.40% |
| 2020-07-31 | -180.14% |
| 2020-04-30 | -173.88% |
| 2019-10-31 | -213.63% |
| 2019-07-31 | -124.20% |
| 2019-04-30 | -165.88% |
| 2019-01-31 | -138.54% |
| 2018-10-31 | -216.96% |
| 2018-07-31 | -167.42% |
| 2017-10-31 | -11.33% |
| 2017-07-31 | -7.71% |
| 2017-01-31 | -654.55% |
